About US
Contact us
-
Lilly USA, diabetes chief Enrique Conterno bows out after 27 yearsEli Lilly's top U.S. executive is on the way out. Enrique Conterno, who heads up Lilly's worldwide diabetes business as well as Lilly USA, is retiring after 27 years at the company. Mike Mason, himse2019/10/16
-
Amgen CFO David Meline, overseer of major restructuring, to retireIn the second half of 2014, Amgen initiated a major overhaul aimed at cutting costs and boosting R&D activities. Now, the chief financial officer tapped on the eve of the revamp is set to bid the2019/10/15
-
NHS England, Vertex cystic fibrosis drug negotiations have 'intensified,' official saysVertexPharmaceuticals and Britishhealth authorities have been stuck in cystic fibrosis (CF) drug pricing negotiations for years, and now those talks have again heated up. National Health Service (NHS2019/10/15
-
Novartis says Ireland site will lose up to 320 jobs as productivity squeeze continuesNovartis CEO Vas Narasimhan credits manufacturing “productivity programs” for helping improve company margins. That productivity tightening will play out next at operations in Ireland where up to 3202019/10/14
-
Retailers pull Johnson & Johnson's baby powder products after asbestos scareJohnson & Johnson investors were sent reeling when the drugmaker pulled some ofits baby powder products off shelves after "sub-trace" amounts of asbestos were found in certain lots. Now, retailer2019/10/14
-
Clinuvel obtains US approval for rare disorder drug ScenesseAustralia-based Clinuvel Pharmaceuticals has received the US Food and Drug Administration (FDA) approval for the use of Scenesse (16mg afamelanotide) to treat erythropoietic protoporphyria (EPP), whi2019/10/11
-
UCB to acquire Ra Pharmaceuticals in $2.1bn dealBelgian biopharmaceutical firm UCB has signed a merger agreement to acquire US-based Ra Pharmaceuticals for $48 per share, totalling $2.1bn in cash. Founded in 2008, Ra Pharma uses its peptide chemis2019/10/11
-
ICER finds lack of evidence to support blockbuster drug price hikesA report by the Institute of Clinical and Economic Review (ICER) has determined that seven of the nine top-selling drugs in the US had limited new clinical evidence of greater patient benefit to just2019/10/10
-
GSK and Lyell partner to develop cell therapies for cancerGlaxoSmithKline (GSK) has partnered with US-based biotechnology firm Lyell Immunopharma to develop technologies to boost cancer cell therapies. Under the five-year partnership, GSK’s cell and gene th2019/10/10
-
J&J’s Janssen to pay $8bn in Risperdal anti-psychotic drug lawsuitA jury at Philadelphia Court of Common Pleas has ordered Johnson & Johnson (J&J) subsidiary Janssen Pharmaceuticals to pay $8bn in punitive damages over its marketing of Risperdal, an anti-ps2019/10/9